NCT06055322

Brief Summary

This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) to reduce suicidality. By adapting this modality, the investigators will provide a scalable intervention tailored for this high-risk population, maximizing the public health impact and improving suicide prevention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jan 2025Aug 2026

First Submitted

Initial submission to the registry

September 12, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 26, 2023

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 7, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

May 11, 2025

Status Verified

May 1, 2025

Enrollment Period

1.6 years

First QC Date

September 12, 2023

Last Update Submit

May 6, 2025

Conditions

Keywords

Suicide IdeationOlder AdultsFamily CaregiversAlzheimer's Disease and Alzheimer's Disease Related DementiasDialectical Behavior Therapy

Outcome Measures

Primary Outcomes (2)

  • Suicide Cognitions Scale-Revised (SCS-R)

    The SCS-R is a 16-item self-report measure that assesses a variety of beliefs, attitudes, expectations, and perceptions associated with the emergence of suicidal thoughts. Importantly, the SCS-R does not directly ask about suicidal thoughts or behaviors, making it an indirect suicide ideation assessment. Previous studies have found that the SCS-R demonstrates excellent internal consistency (α = .96-.98; Bryan et al., 2021; Moscardini et al., 2020).

    All 18 timepoints

  • Beck Scale for Suicide Ideation (BSSI)

    The BSSI is a 21-item self-report measure with 19 items to evaluate the current intensity of patients' specific attitudes, behaviors, and plans for suicide, including desire for suicide (suicide ideation) and desire for death generally (death ideation). Two items also assess suicide attempt history and intent during the most recent suicide attempt (if applicable). The BSSI has demonstrated good psychometric properties and has good predictive validity for suicide death (Beck et al., 1997; Brown et al., 2000), including among aging adults (Witte et al., 2006).

    through study completion, an average of 6 months

Secondary Outcomes (11)

  • Interpersonal Needs Questionnaire (INQ)

    through study completion, an average of 6 months

  • Geriatric Depression Scale (GDS)

    through study completion, an average of 6 months

  • Difficulty in Emotion Regulation Scale (DERS)

    through study completion, an average of 6 months

  • The Distress Tolerance Scale (DTS)

    through study completion, an average of 6 months

  • Interpersonal Sensitivity Scale (INT)

    through study completion, an average of 6 months

  • +6 more secondary outcomes

Study Arms (1)

Adapted Dialectical Behavior Therapy

EXPERIMENTAL

Adapting Dialectical Behavior Therapy to focus on reducing suicide ideation for family caregivers of persons with AD/ADRD

Behavioral: Adapted Dialectical Behavior Therapy

Interventions

DBT includes skills training groups, unlike other suicide-specific treatments, with modules on distress tolerance, emotion regulation, interpersonal effectiveness, and mindfulness (Linehan, 2014)

Adapted Dialectical Behavior Therapy

Eligibility Criteria

Age50 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being age 50 and over (as most informal caregivers of persons with AD/ADRD are 50 or older; AARP, 2020; Chi et al., 2019)
  • being the primary informal caregiver
  • living with an AD/ADRD-diagnosed patient
  • being willing to be prodded for bloodspots
  • demonstrating English-fluency
  • endorsing a direct or indirect SI/suicide risk
  • Eligible individuals will score above clinical cutoffs for SI/suicide risk on at least 1 of 3 measures: the Suicide Behavior Questionnaire-R (SBQ-R; score \> 6; Osman et al., 2002), Interpersonal Needs Question-naire (INQ; thwarted belonging score \> 35; and perceived burden \> 17; Mitchell et al., 2020) or the Geriatric De-pression Scale (GDS; score \> 5 Heisel et al., 2005).

You may not qualify if:

  • Participants with neurocognitive impairment will be excluded (a Mini-Mental State Exam score ≤ 23; Folstein et al., 1975; Kochhann et al., 2010)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Garrison Institute on Aging

Lubbock, Texas, 79413, United States

RECRUITING

MeSH Terms

Conditions

SuicideDepressionCaregiver BurdenInflammationAlzheimer Disease

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehaviorStress, PsychologicalPathologic ProcessesPathological Conditions, Signs and SymptomsDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Jonathan D Singer, PhD

CONTACT

Sean Mitchell, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Adapted Dialectical Behavior Therapy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2023

First Posted

September 26, 2023

Study Start

January 7, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

May 11, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

The investigators will not be providing any individual participant data. It will all be aggregate

Locations